
Fischer Medical Ventures Q2 Results FY27: PAT Falls 94.24% to Rs 0.80 Cr, Revenue Rs 107.44 Cr
Updated: 15 Nov 2026 • 12:12 am
Posted by:

Quick Answer
Fischer Medical Ventures Q2 Results FY27 were declared on 14 November 2026 on a consolidated basis. Revenue rose 24.48% YoY to Rs 107.44 Cr, while net profit fell 94.24% YoY to Rs 0.80 Cr from Rs 13.90 Cr. These quarterly results also show Operating Profit of Rs 8.94 Cr, down 45.02% from Rs 16.26 Cr, so YoY growth in revenue came with lower profit lines.
Fischer Medical Ventures Ltd (FISCHER) Q2 Results FY27 announced on 14 November 2026, covering the company's financial performance for the July to September quarter. In the Fischer Medical Ventures Q2 Results FY27 filing, the company reported revenue of Rs 107.44 Cr and net profit (PAT) of Rs 0.80 Cr. The results date of 14 November 2026 applies to these results, and the results basis is Consolidated.
This Fischer Medical Ventures Q2 Results analysis covers the financial highlights, the business drivers, the outlook and the risks. The results analysis begins with the Financial Highlights table that follows, which sets this quarter against the same quarter last year.
Click Here – Get Free Investment Predictions
Fischer Medical Ventures Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 107.44 Cr | Rs 86.31 Cr | +24.48% YoY |
| Operating Profit | Rs 8.94 Cr | Rs 16.26 Cr | -45.02% YoY |
| Net Profit (PAT) | Rs 0.8 Cr | Rs 13.9 Cr | -94.24% YoY |
Source: company filing for Fischer Medical Ventures Q2 Results FY27, 14 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Fischer Medical Ventures Q2 Results: What Stands Out
- Revenue: Rs 107.44 Cr against Rs 86.31 Cr a year ago, which is YoY growth of 24.48% on a consolidated basis for the quarter.
- Net profit: Rs 0.80 Cr against Rs 13.90 Cr in the same quarter last year, a fall of 94.24% YoY.
- Operating Profit: Rs 8.94 Cr against Rs 16.26 Cr a year ago, down 45.02% YoY in the Fischer Medical Ventures Q2 Results FY27 filing.
- Sequential revenue: Revenue was up 31.2% quarter on quarter from Rs 81.92 Cr, which is the sequential comparison for the quarter.
- Next step: The performance analysis below places these YoY figures side by side and shows revenue and net profit moving in opposite directions.
Fischer Medical Ventures Q2 Results FY27: Performance Analysis
Fischer Medical Ventures Q2 Results FY27 show revenue of Rs 107.44 Cr, up 24.48% YoY, and net profit of Rs 0.80 Cr, down 94.24% YoY. Operating Profit was Rs 8.94 Cr, down 45.02%. Revenue therefore rose while both profit lines fell on a consolidated basis.
The Fischer Medical Ventures Q2 Results analysis can also be read sequentially. Revenue of Rs 107.44 Cr compares with Rs 81.92 Cr in the previous quarter, an increase of 31.2%. Against Rs 86.31 Cr a year ago, the YoY growth is 24.48%, while net profit moved from Rs 13.90 Cr to Rs 0.80 Cr.
Investors tracking Fischer Medical Ventures Q2 Results FY27 will see that net profit margin was 0.7% against 16.1% in the comparison quarter. The results analysis therefore centres on how profit relates to revenue, which is where the quarterly results turn to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue growth – The results analysis points first to revenue, which grew 24.5% year on year to Rs 107.44 Cr in the latest quarter. This is the first business factor disclosed for the quarter, and it sits against net profit of Rs 0.80 Cr in the Fischer Medical Ventures Q2 Results FY27 filing.
Sequential revenue – Revenue was up 31.2% quarter on quarter from Rs 81.92 Cr. The latest quarterly results therefore stand higher than the quarter before them, alongside the YoY growth already noted for the quarter.
Return on equity – Return on equity improved to 9.38% in FY26 from 0.87% in FY25. This annual measure is reported separately from the quarterly net profit of Rs 0.80 Cr, and it leads into the FY27 outlook below.
FY27 Outlook After Fischer Medical Ventures Q2 Results
This results analysis keeps the FY27 outlook to what the reported numbers allow. FY27 full-year results will depend on the quarters that follow, and the net profit of Rs 0.80 Cr in this quarter is one input into that full-year picture.
Fischer Medical Ventures Q2 Results FY27 give two reference points for the coming quarters: revenue of Rs 107.44 Cr and Operating Profit of Rs 8.94 Cr. Disclosed sector conditions and later filings will show how both lines develop, and the risks below frame what to watch next.
Key Risks to Watch After Fischer Medical Ventures Q2 Results FY27
Net profit fell 94.2% year on year
Net profit fell 94.2% year on year to Rs 0.80 Cr, against Rs 13.90 Cr in the same quarter last year. This is the largest change in the Fischer Medical Ventures Q2 Results FY27 figures and the first item to track in later filings.
Net profit margin narrowed to 0.7%
Net profit margin narrowed to 0.7% from 16.1% in the comparison quarter, even though revenue recorded YoY growth of 24.48%. The gap between revenue and profit is therefore a risk that investors can follow in each new quarter.
Quarterly net profit has been volatile
Quarterly net profit has been volatile, ranging from Rs -7.10 Cr to Rs 19.24 Cr over the last 5 quarters, so each new net profit figure is best read against that recent range before the conclusion.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Fischer Medical Ventures Q2 Results FY27 combine revenue of Rs 107.44 Cr with net profit of Rs 0.80 Cr. These quarterly results are consolidated results, so every figure applies on that basis. The Fischer Medical Ventures Q2 Results can be tracked further on the Univest app and the Univest Screener. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Fischer Medical Ventures Q2 Results FY27
What are Fischer Medical Ventures Q2 Results FY27?
Ans. Fischer Medical Ventures Q2 Results FY27 cover the July to September 2026 quarter and were declared on 14 November 2026, with revenue of Rs 107.44 Cr, as summarised in the Quick Answer box at the top of this article.
What is the results date for Fischer Medical Ventures Q2 Results FY27?
Ans. The results date for Fischer Medical Ventures Q2 Results FY27 is 14 November 2026, when Fischer Medical Ventures declared the consolidated results, as stated in the opening paragraphs of this article.
What revenue was reported in Fischer Medical Ventures Q2 Results FY27?
Ans. Fischer Medical Ventures Q2 Results FY27 reported revenue of Rs 107.44 Cr against Rs 86.31 Cr a year ago, which is the figure shown in the Financial Highlights table and in the Key Takeaways section.
What net profit was reported in Fischer Medical Ventures Q2 Results FY27?
Ans. Fischer Medical Ventures Q2 Results FY27 reported net profit of Rs 0.80 Cr against Rs 13.90 Cr in the same quarter last year, as covered in the Performance Analysis section of this article.
How much YoY growth did revenue show in Fischer Medical Ventures Q2 Results FY27?
Ans. Revenue showed YoY growth of 24.48% in Fischer Medical Ventures Q2 Results FY27, rising from Rs 86.31 Cr to Rs 107.44 Cr, while the Performance Analysis section also covers the 31.2% quarter on quarter increase.
Did net profit rise or fall in Fischer Medical Ventures Q2 Results?
Ans. Fischer Medical Ventures Q2 Results show net profit falling 94.24% YoY to Rs 0.80 Cr, which means revenue and net profit moved in opposite directions, as explained in the Performance Analysis section.
What was the Operating Profit in Fischer Medical Ventures Q2 Results FY27?
Ans. Operating Profit in Fischer Medical Ventures Q2 Results FY27 was Rs 8.94 Cr against Rs 16.26 Cr a year ago, a fall of 45.02% YoY, as listed in the Key Takeaways section.
Are Fischer Medical Ventures Q2 Results consolidated results or standalone results?
Ans. Fischer Medical Ventures Q2 Results are consolidated results, so the revenue of Rs 107.44 Cr and net profit of Rs 0.80 Cr apply on that basis, as stated in the Quick Answer box.
What business factors shaped Fischer Medical Ventures Q2 Results FY27?
Ans. The business factors in Fischer Medical Ventures Q2 Results FY27 are revenue growth of 24.5% YoY, a 31.2% sequential rise and return on equity of 9.38% in FY26, which the Key Business Factors section explains.
What are the key risks after Fischer Medical Ventures Q2 Results FY27?
Ans. The key risks after Fischer Medical Ventures Q2 Results FY27 are the 94.2% fall in net profit, the margin at 0.7% and the volatile quarterly net profit range, which the Key Risks section sets out.
What is the outlook after Fischer Medical Ventures Q2 Results?
Ans. The outlook after Fischer Medical Ventures Q2 Results depends on later quarters, so FY27 full-year results will follow the quarters ahead, as the FY27 Outlook section explains using the reported numbers.
Where can I find the complete Fischer Medical Ventures Q2 Results FY27 data?
Ans. The complete Fischer Medical Ventures Q2 Results FY27 figures sit in the Financial Highlights table of this article, which compares revenue, Operating Profit and net profit with last year. Investors can also follow the company on the Univest Screener.
Recent Articles

DCM Shriram Fine Chemicals Q2 Results FY27: Net Loss Rs 0.08 Cr, Revenue Rs 89.97 Cr
14 November 2026

SRM Contractors Q2 Results FY27: Net Profit Rises 49.6% to Rs 30.04 Cr, Revenue Rs 303.50 Cr
14 November 2026

Available Finance Q2 Results FY27: Net Profit Jumps 132.42% to Rs 54.27 Cr, Revenue Rs 0.16 Cr
14 November 2026

Lancor Holdings Q2 Results FY27: Revenue Rs 35.88 Cr Up 6.31%, Net Loss Narrows to Rs 0.40 Cr
14 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
DCM Shriram Fine Chemicals Q2 Results FY27: Net Loss Rs 0.08 Cr, Revenue Rs 89.97 Cr
SRM Contractors Q2 Results FY27: Net Profit Rises 49.6% to Rs 30.04 Cr, Revenue Rs 303.50 Cr
Available Finance Q2 Results FY27: Net Profit Jumps 132.42% to Rs 54.27 Cr, Revenue Rs 0.16 Cr
Lancor Holdings Q2 Results FY27: Revenue Rs 35.88 Cr Up 6.31%, Net Loss Narrows to Rs 0.40 Cr
Jindal Poly Films Q2 Results FY27: Revenue Rs 738.07 Cr Up 79.85%, Net Loss Rs 85.17 Cr
Popular this week
Jeena Sikho Lifecare Q2 Results FY27: Revenue Rs 235.13 Cr, PAT Rs 36.63 Cr, Profit Falls 37.65%

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





